You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • SAT0198 Tocilizumab for the management of rheumatoid arthritis: discontinuation due to inefficacy and toxicity – experience from a large teaching hospital

Citation Tools

Article menu

Download PDFPDF

Poster Presentations
Rheumatoid arthritis - other biologic treatment
SAT0198 Tocilizumab for the management of rheumatoid arthritis: discontinuation due to inefficacy and toxicity – experience from a large teaching hospital
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Byrne E, Mark P, Khalid S, et al
SAT0198 Tocilizumab for the management of rheumatoid arthritis: discontinuation due to inefficacy and toxicity – experience from a large teaching hospital
Annals of the Rheumatic Diseases 2017;76:847.